ResearcherUniversity of California San DiegoActive in the last 2 years
Gregory M. Heestand
Matched on ORCID iD 0000-0002-2255-8377; OpenAlex author ID A5004560681. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? Co-author DOI 10.1097/sla.0000000000006609↗
- A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. Co-author DOI 10.1371/journal.pone.0147995↗
- Approach to patients with pancreatic cancer without detectable metastases. Co-author DOI 10.1200/jco.2014.59.7930↗
- Molecular landscape of pancreatic cancer: implications for current clinical trials. Co-author DOI 10.18632/oncotarget.2972↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel Tandel Chang · 2 shared papers, 2016–2026 · strength 0.30
- Paper Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is B… DOI 10.1097/sla.0000000000006609↗
- Paper A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NC… DOI 10.1371/journal.pone.0147995↗
- George A. Poultsides · 1 shared paper, 2026 · strength 0.24
- M. Usman Ahmad · 1 shared paper, 2026 · strength 0.24
- Byrne Lee · 1 shared paper, 2026 · strength 0.24
- Daniel Delitto · 1 shared paper, 2026 · strength 0.24
- Brendan Christopher Visser · 1 shared paper, 2026 · strength 0.24
- Erqi Liu Pollom · 1 shared paper, 2026 · strength 0.24
- Amanda Kirane · 1 shared paper, 2026 · strength 0.24
- Jeffrey Allen Norton · 1 shared paper, 2026 · strength 0.24
- George Albert Fisher · 1 shared paper, 2026 · strength 0.24
- Razelle Kurzrock · 1 shared paper, 2015 · strength 0.11
- Andrew M. Lowy · 1 shared paper, 2015 · strength 0.08
- James Don Murphy · 1 shared paper, 2015 · strength 0.08
- Albert C. Koong · 1 shared paper, 2016 · strength 0.05
- David Benjamin Shultz · 1 shared paper, 2016 · strength 0.05
- Wendy R. Parulekar · 1 shared paper, 2016 · strength 0.05
- Malcolm J. Moore · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.